Oncotarget’s Top 10 Most-Viewed Papers in 2021
Read the 10 most-viewed oncology-focussed papers on Oncotarget.com in 2021.—#10: Metformin and... read more
January 21, 2022
Author: Oncotarget
Open-Access Oncotarget Shifts to Continuous Publishing
As of 2022, the peer-reviewed and open-access journal Oncotarget has shifted to continuous... read more
January 6, 2022
Table of Contents: Oncotarget’s Volume 12, Issue 26
Read short summaries of the latest oncology-focused research published in this week’s issue of... read more
December 21, 2021
Table of Contents: Oncotarget’s Volume 12, Issue 25
Read short summaries of the latest oncology-focused research published in this week’s issue of... read more
December 7, 2021
Table of Contents: Oncotarget’s Volume 12, Issue 24
Read short summaries of the latest oncology-focused research published in this week’s issue of... read more
November 23, 2021
Table of Contents: Oncotarget’s Volume 12, Issue #23
Read short summaries of the latest oncology-focused research published in this week’s issue of... read more
November 9, 2021
Table of Contents: Oncotarget’s Volume 12, Issue #22
Read short summaries of the latest oncology-focused research published in this week’s issue of... read more
October 26, 2021
Table of Contents: Oncotarget’s Volume 12, Issue #21
Read short summaries of the latest oncology-focused research published in this week’s issue of&... read more
October 12, 2021
Table of Contents: Oncotarget’s Volume 12, Issue #20
Read short summaries of the latest oncology-focused research published in this week’s issue of... read more
September 28, 2021
Behind the Study: Populations of Cells Resistant to EMT
Dr. Herbert Levine and Dr. Mohit Kumar Jolly describe their research that... read more
September 27, 2021